ServicenavigationHauptnavigationTrailKarteikarten


Research unit
EU RFP
Project number
00.0140
Project title
CANCER and MSI: Novel approaches towards the diagnosis and therapy of tumours with microsatellite instability.

Texts for this project

 GermanFrenchItalianEnglish
Key words
-
-
-
Anzeigen
Alternative project number
-
-
-
Anzeigen
Research programs
-
-
-
Anzeigen
Short description
-
-
-
Anzeigen
Further information
-
-
-
Anzeigen
Partners and International Organizations
-
-
-
Anzeigen
Abstract
-
-
-
Anzeigen
References in databases
-
-
-
Anzeigen

Inserted texts


CategoryText
Key words
(English)
Colon cancer; HNPCC; microsatellite instability; mismatch repair; chemotherapy;
Life Sciences; Medicine; Health; Scientific Research
Alternative project number
(English)
EU project number: QLG1-CT-2000-01230
Research programs
(English)
EU-programme: 5. Frame Research Programme - 1.1.8 Generic R&D activities
Short description
(English)
See abstract
Further information
(English)
Full name of research-institution/enterprise:
Universität Zürich
Institute of Melecular Cancer Research
Partners and International Organizations
(English)
University of Leiden (NL), Istituto Superiore di Sanita (I), Istituto Dermopatico dell'Immaccolata (I), University of Helsinki (FIN), University of Roskilde (DK), Slovak Academy of Sciences (SK)
Abstract
(English)
A large percentage of tumours from hereditary non-polyposis colon cancer (HNPCC) patients, as well as more than 15% of sporadic colon tumours, display microsatellite instability (MSI) , which has been linked to a defect in mismatch correction (MMR) . Tumour cells with high MSI (MSI-H) differ from other cancer cells: they are largely diploid and the oncogenes and tumour suppressor genes mutated in them are frequently different from those altered in sporadic disease without MSI. We shall compare the response of normal and MSI-H cells to a series of chemotherapeutic and radio-mimetic agents, as well as to ionising and non-ionising radiation. The principal aim of this program is to exploit the identified differences in cancer therapy, by devising ways of selectively killing cells with MSI. The second goal of the study is to use our findings to develop new, facile, diagnostic strategies for the identification of at-risk individuals.
References in databases
(English)
Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. +41 31 322 74 82
Swiss Project-Number: 00.0140